Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Bipolar disorder is a chronic psychiatric condition characterised by recurrent episodes of mania and depression.

Methods: Our study analyzed the data from the Global Burden of Disease (GBD) study, covering the years 1990 to 2021. This dataset includes key metrics such as incidence, prevalence, disability-adjusted life years (DALYs), years lived with disability (YLDs), and age-standardized rates. By utilizing the Socio-demographic Index (SDI) quintiles and the XGBoost model, we sought to assess and predict the long-term impact of regional economic disparities and sociodemographic factors on the burden of bipolar disorder.

Results: Our study indicates that the global incidence of bipolar disorder has been steadily increasing, rising significantly from 30,239,332 cases in 1990 to 53,917,371 cases in 2021. This increase predominantly affects women and adolescent populations. Moreover, a significant positive correlation exists between the burden of bipolar disorder and the SDI. Developed countries generally show higher age-standardized incidence rates, age-standardized mortality rates, and age-standardized DALY rates than developing countries. However, the rise in disease burden is more pronounced in economically underdeveloped regions than in developed areas.

Conclusion: From 1990 to 2021, the global burden of bipolar disorder has shown a persistent upward trend, with marked disparities observed across regions with varying SDI levels. High-SDI regions consistently demonstrate elevated incidence and prevalence rates, whereas low-SDI regions are grappling with a progressively significant disease burden. These findings highlight the need for increased investment in the global mental healthcare system. Particular priority should be given to strengthening support for healthcare systems in low-income and resource-poor areas.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2025.119638DOI Listing

Publication Analysis

Top Keywords

bipolar disorder
20
burden bipolar
16
global burden
12
burden
8
data global
8
burden disease
8
1990 2021
8
incidence prevalence
8
rates age-standardized
8
disease burden
8

Similar Publications

Background: Bipolar disorder (BD) is a complex mood disorder among the leading causes of disability worldwide. Internalized stigma refers to the awareness of negative stereotypes adopted by society and the agreement with these judgments, often associated with impaired functionality and social adaptation. Studies examining internalized stigma and related factors in BD are limited.

View Article and Find Full Text PDF

Unlabelled: Mood disorders, including major depressive disorder (MDD) and bipolar disorder (BP), significantly impact global health, with MDD affecting over 300 million people and BP affecting approximately 2% of the world's population. Ketamine, originally an anesthetic, has emerged as a promising treatment for patients with treatment-resistant depression (TRD), due to its unique pharmacological properties, such as N-methyl-D-aspartate (NMDA) receptor antagonism and anti-inflammatory effects. The potential of ketamine in treating depression has sparked debate regarding its effects on appetite.

View Article and Find Full Text PDF

Objective: In bipolar disorder, residual mood symptoms often persist even during the euthymic period, impairing functionality in 30-60% of patients in clinical remission. Addressing residual symptoms is critical as they are linked to reduced functionality and subjective wellbeing. This cross-sectional study aimed to determine the relationship between mindful attention awareness (MASS) and residual symptom severity in bipolar I disorder.

View Article and Find Full Text PDF

Phenothiazine Derivatives and Their Impact on the Apoptosis Processes: A Review.

J Appl Toxicol

September 2025

Department of Drug and Cosmetics Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.

Phenothiazine derivatives have been used for decades as antipsychotic drugs in multiple mental health and physical conditions treatment (schizophrenia, mania in bipolar disorder, and psychosis). Epidemiological studies have shown that people with schizophrenia are less likely to suffer from cancer, which indicates the ability of antipsychotics to inhibit the development of cancer cells. It is our third review about the impact of phenothiazine derivatives on cell death.

View Article and Find Full Text PDF

Bipolar disorder (BD) is a debilitating mental illness characterized by significant mood swings, posing a substantial challenge for accurate diagnosis due to its clinical complexity. This paper presents CS2former, a novel approach leveraging a dual channel-spatial feature extraction module within a Transformer model to diagnose BD from resting-state functional MRI (Rs-fMRI) and T1-weighted MRI (T1w-MRI) data. CS2former employs a Channel-2D Spatial Feature Aggregation Module to decouple channel and spatial information from Rs-fMRI, while a Channel-3D Spatial Attention Module with Synchronized Attention Module (SAM) concurrently computes attention for T1w-MRI feature maps.

View Article and Find Full Text PDF